FTC Releases Second Interim Staff Report on Prescription Drug …
Jan 14, 2025 · The FTC’s second interim staff report analyzed all specialty generic drugs dispensed from 2017 to 2022 for members of commercial health plans and Medicare Part D prescription drug plans managed by the Big 3 PBMs for which the FTC has relevant data.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of ...
PBMs Challenge FTC Enforcement Authority In Federal Court
Dec 11, 2024 · Specifically, there has been heightened tension between the Federal Trade Commission (FTC) and the largest PBMs in the United States since 2022, when FTC launched an extensive investigation...
FTC doubles down on PBM criticism in new report
3 days ago · Last year, the Federal Trade Commission (FTC) caused consternation among pharmacy benefit managers (PBMs) after it claimed the middlemen in the pharma supply chain were ramping up costs for...
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
Jul 20, 2024 · Now, PBMs are center stage for the FTC. The Federal Trade Commission has turned its attention to these powerful intermediaries and is, according to the Wall Street Journal, considering a...
FTC case against Caremark, Express Scripts, Optum Rx can move …
Feb 20, 2025 · The FTC’s lawsuit against Caremark, Express Scripts and Optum Rx — known as the “Big Three” PBMs for their outsized control of the U.S. prescription market — hinges on allegations the ...
PBMs made billions marking up specialty drugs by more than …
Jan 14, 2025 · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through...
FTC report: Pharmacy benefit managers profit at expense of ... - CNN
Jul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC Accuses Drug Managers Of Squeezing Patients And Pharmacies - Forbes
Jul 11, 2024 · The FTC blasted pharmacy benefit managers, accusing them of raising patients’ costs and driving pharmacies out of business. The FTC is planning to sue the 3 largest PBMs.